AI assistant
Sending…
IMMUCELL CORP /DE/ — Director's Dealing 2022
May 18, 2022
34519_dirs_2022-05-18_5c255296-d737-4c20-a0fb-070f79773e07.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2022-05-16
Reporting Person: Tomsche David Scott (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-05-16 | Common Stock, par value $0.10 per share | D | 200.0000 | $8.3500 | Acquired | 100719.0000 | Direct |
| 2022-05-17 | Common Stock, par value $0.10 per share | D | 3400.0000 | $8.3700 | Acquired | 104119.0000 | Direct |
More from IMMUCELL CORP /DE/
Regulatory Filings
2026
May 14
Annual Report
2026
May 13
Regulatory Filings
2026
May 8
Proxy Solicitation & Information Statement
2026
Apr 24
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 8
Annual Report
2026
Mar 30
Director's Dealing
2026
Mar 25
Director's Dealing
2026
Mar 23